JOSEPH MUENZER

Allopathic & Osteopathic Physicians|Pediatrics CHAPEL HILL, NC NPI 1306926944

General Payments — all program years on this page

$334,811.98

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 225
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $27,157.32 across 10 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
SANOFI-AVENTIS U.S. LLC $20,943.635
Takeda Pharmaceuticals U.S.A., Inc. $3,664.913
GENZYME CORPORATION $2,456.001
Ultragenyx Pharmaceutical Inc. $92.781

By program year

Program yearAmountRecords
2018 $108,891.3798
2019 $102,240.3580
2020 $17,985.6412
2021 $14,286.006
2022 $29,044.9311
2023 $35,206.378
2024 $27,157.3210

Records — PY2024 (10)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1137639226 Takeda Pharmaceuticals U.S.A., Inc. $869.47 02/28/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137639228 Takeda Pharmaceuticals U.S.A., Inc. $1,304.88 08/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1137639230 Takeda Pharmaceuticals U.S.A., Inc. $1,490.56 12/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1139590140 GENZYME CORPORATION $2,456.00 06/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1139590164 SANOFI-AVENTIS U.S. LLC $9,769.00 11/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1139590170 SANOFI-AVENTIS U.S. LLC $10,077.40 11/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139590172 SANOFI-AVENTIS U.S. LLC $171.22 11/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139590174 SANOFI-AVENTIS U.S. LLC $280.70 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139590176 SANOFI-AVENTIS U.S. LLC $645.31 11/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1153281558 Ultragenyx Pharmaceutical Inc. $92.78 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.